Innorna
PrivateLast Round
IPO
Oct 22, 2025
Est. Valuation
$480M
Total Funding Raised
$120M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Innorna operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series B round in March 2022.
Innorna is a biotechnology company that develops mRNA-based medicines and proprietary lipid nanoparticle (LNP) delivery systems to treat chronic diseases, power in vivo immunotherapies, and prevent infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innorna Comparables
Compare Innorna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immorna Biotherapeutics | 89% | |
| Immorna | 88% | |
| RVAC Medicines | 88% |
For institutional investors. Book with your work email.
Innorna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 22, 2025 | ||||
| Series B | Mar 28, 2022 | ||||
| Series A | Jul 22, 2021 | ||||
| Angel | Nov 1, 2020 |
For institutional investors. Book with your work email.
Innorna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Optimas Capital | Series B |
| Huasheng Capital | Series B |
| Hong Kong Science and Technology Parks Corporation | Series B |
| Legend Capital | Series A |
| CITIC Private Equity Funds Management | Series B |
| Fangyuan Capital (Hong Kong) Limited | Series B |
| CAS Star | Series A, Angel |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 86% MoM.
- Jul 27, 2026
Monthly visitors grew 137% MoM, reaching 1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asAug 13, 2026
On Aug 13th '26, Innorna announces its nomination for the 2026 Prix Galien USA Best Startup Award in China and Massachusetts after being shortlisted in the Best Startup category; the awards ceremony takes place on Oct 29th '26 at the American Museum of Natural History in New York.
- recognized_asAug 13, 2026
Innorna is nominated for the 2026 Prix Galien USA Best Startup Award and shortlisted in the Best Startup category, with the Prix Galien USA recognition reflecting its innovative mRNA-LNP platform and clinical portfolio beyond vaccines into therapeutics, on Aug 13th '26 in China and Massachusetts.
- receives_financingAug 13, 2026
Innorna Co. receives financing of $150M in equity financing.
- receives_awardAug 13, 2026
Innorna is nominated for the 2026 Prix Galien USA Best Startup Award, with winners announced at the 2026 Prix Galien USA Awards ceremony on Oct 29th '26 at the American Museum of Natural History in New York City.
- recognized_asAug 13, 2026
Innorna is nominated for the 2026 Prix Galien USA Best Startup Award and shortlisted in the Best... selection, as announced on Aug 13th '26.
For institutional investors. Book with your work email.
Innorna Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Innorna's valuation, stock price, and market status.
Is Innorna a public or private company?
Innorna is a private company.
What is the current stock price of Innorna?
Innorna is a private company, so its shares have no public market price. Caplight tracks Innorna's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Innorna worth (valuation)?
Innorna's valuation is estimated at $480.0M based on funding round data.
Can I buy Innorna stock?
Innorna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Innorna's last funding round?
Innorna's most recent funding round was IPO on October 22, 2025.
Who are the main investors in Innorna?
Key investors in Innorna include Huasheng Capital, CDH Investments, CPE.
Will Innorna IPO soon?
No public IPO plans have been announced for Innorna.
How can I track Innorna secondary market activity?
Caplight tracks bids, offers, and trades in Innorna's shares on secondary markets.